Back
Genmab AS Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
17
GMAB
Genmab AS
Last Price:
25.54
Seasonality Move:
6.18%
Sell
41
ASND
Ascendis Pharma AS
Last Price:
151.30
Seasonality Move:
6.54%
Sell
17
Genmab AS (GMAB)
is a Sell
Is Genmab AS a Buy, Sell or Hold?
- The current Genmab AS [GMAB] share price is $25.53. The Score for GMAB is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- GMAB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
41
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
- The current Ascendis Pharma AS [ASND] share price is $151.26. The Score for ASND is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $151.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
GMAB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.31 | Sell |
Relative Strength Index (14 RSI): | 33.51 | Sell |
Chaikin Money Flow: | -501913 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.57 - 27.75) | Sell |
Bollinger Bands (100): | (26.14 - 28.66) | Sell |
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.26 | Buy |
Relative Strength Index (14 RSI): | 67.99 | Buy |
Chaikin Money Flow: | -1404982 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (121.19 - 145.49) | Buy |
Bollinger Bands (100): | (125.23 - 140.47) | Buy |
GMAB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.44 | Sell |
20-day SMA: | 27.13 | Sell |
50-day SMA: | 27.25 | Sell |
200-day SMA: | 28.56 | Sell |
8-day EMA: | 26.42 | Sell |
20-day EMA: | 26.85 | Sell |
50-day EMA: | 27.1 | Sell |
200-day EMA: | 28.96 | Sell |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 135.74 | Buy |
20-day SMA: | 132.11 | Buy |
50-day SMA: | 133.55 | Buy |
200-day SMA: | 135.84 | Buy |
8-day EMA: | 140.77 | Buy |
20-day EMA: | 134.62 | Buy |
50-day EMA: | 133.51 | Buy |
200-day EMA: | 129.9 | Buy |
Genmab AS Earnings Growth & GMAB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.10 per share, an increase this year of $0.15 per share, and an increase next year of $0.33 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.77 per share, an increase next quarter of $1.52 per share, an increase this year of $1.67 per share, and an increase next year of $4.42 per share.
Genmab AS Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ascendis Pharma AS Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |